Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578
- PMID: 34236145
- PMCID: PMC8364990
- DOI: 10.1111/1759-7714.14059
Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578
Abstract
Background: Circular RNAs (circRNAs) had been identified as a non-coding RNA associated with many types of cancer in recent years. However, the involvement of hsa_circ_0008274 in lung adenocarcinoma (LUAD) has not been explored. The aim of our research is to explore the biological mechanism and function of hsa_circ_0008274 in LUAD.
Methods: The hsa_circ_0008274, miR-578, and high mobility group AT-Hook 2 (HMGA2) mRNA expression levels were detected via qRT-PCR. Cell Counting Kit-8 (CCK-8) Transwell assay and wound healing assay were performed to measure the cell proliferation, invasion, and migration ability. Luciferase reporter and Western blotting experiments were performed to characterize the competing endogenous RNA (ceRNA) mechanism of hsa_circ_0008274.
Results: Our findings determined that the expression of hsa_circ_0008274 in LUAD was significantly decreased. Cell experiments showed that overexpressed hsa_circ_0008274 could reduce the proliferation and invasion ability of LUAD cells. Moreover, miRNA-578 could identify as a miRNA sponge of hsa_circ_0008274. Overexpressed hsa_circ_0008274 reduced the proliferation and invasion of LUAD cells caused by miR-578 mimics. Increasing the expression of miR-578 can aggravate the proliferation and invasion of LUAD cells and block the inhibition of proliferation and invasion of LUAD cells mediated by overexpressed hsa_circ_0008274. Subsequent data indicate that HMGA2 of the tumor-promoting gene is the target gene of miR-578. The upregulation of HMGA2 partially reversed the tumor inhibitory effect of LUAD cells induced by overexpressed hsa_circ_0008274 or miR-578 mimics.
Conclusions: In summary, our data show that the overexpression of hsa_circ_0008274 repressed the proliferation and invasion of LUAD through downregulating miR-578 and activating HMGA2.
Keywords: HMGA2; hsa_circ_0008274; lung adenocarcinoma; miR-578.
© 2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflict of interests.
Figures




Similar articles
-
Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.Cancer Biomark. 2023;37(1):53-66. doi: 10.3233/CBM-220282. Cancer Biomark. 2023. PMID: 37005879
-
The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.Cell Mol Biol Lett. 2019 Dec 26;24:72. doi: 10.1186/s11658-019-0198-1. eCollection 2019. Cell Mol Biol Lett. 2019. Retraction in: Cell Mol Biol Lett. 2024 Jun 11;29(1):86. doi: 10.1186/s11658-024-00604-7. PMID: 31889960 Free PMC article. Retracted.
-
Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis.Cell Death Dis. 2021 Mar 24;12(4):313. doi: 10.1038/s41419-021-03601-2. Cell Death Dis. 2021. PMID: 33762580 Free PMC article.
-
CircRNAs in Lung Adenocarcinoma: Diagnosis and Therapy.Curr Gene Ther. 2022;22(1):15-22. doi: 10.2174/1566523221666211202095258. Curr Gene Ther. 2022. PMID: 34856899 Review.
-
The Emerging Role of Circ-SHPRH in Cancer.Onco Targets Ther. 2021 Jul 13;14:4177-4188. doi: 10.2147/OTT.S317403. eCollection 2021. Onco Targets Ther. 2021. PMID: 34285509 Free PMC article. Review.
Cited by
-
Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR-578/EPSTI1 axis.Thorac Cancer. 2023 Sep;14(26):2665-2677. doi: 10.1111/1759-7714.15053. Epub 2023 Aug 2. Thorac Cancer. 2023. PMID: 37533139 Free PMC article.
-
Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma.Front Oncol. 2022 Oct 17;12:1031728. doi: 10.3389/fonc.2022.1031728. eCollection 2022. Front Oncol. 2022. PMID: 36324565 Free PMC article.
-
Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review).Int J Oncol. 2023 Feb;62(2):21. doi: 10.3892/ijo.2022.5469. Epub 2022 Dec 23. Int J Oncol. 2023. PMID: 36562354 Free PMC article.
-
circSTRN3 aggravates sepsis-induced acute kidney injury by regulating miR-578/ toll like receptor 4 axis.Bioengineered. 2022 May;13(5):11388-11401. doi: 10.1080/21655979.2022.2061293. Bioengineered. 2022. PMID: 35510365 Free PMC article.
-
CircGPC3 promotes hepatocellular carcinoma progression and metastasis by sponging miR-578 and regulating RAB7A/PSME3 expression.Sci Rep. 2024 Apr 1;14(1):7632. doi: 10.1038/s41598-024-58004-y. Sci Rep. 2024. PMID: 38561366 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
-
- Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, Thomas C, et al. Clinical cancer advances 2009: major research advances in cancer treatment, prevention, and screening–a report from the American Society of Clinical Oncology. J Clin Oncol. 2009;27:6052–69. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical